Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22
Phase 32

Trial Status

Completed1
Recruiting1
Terminated1
Other2

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT05673590Phase 3Unknown
Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PrincipalinvestigatorStart date: 2023-05-12
NCT04900363Phase 1/2Completed
A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC
Non-small Cell Lung Cancer
PrincipalinvestigatorStart date: 2021-05-21
NCT03838848Phase 2Terminated
KN046 in Patients With Advanced Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer
PrincipalinvestigatorStart date: 2019-05-05

Research Network

Collaboration Network

7 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Solid TumorCarcinoma, Non-Small-Cell LungStage IV Non-small Cell Lung Cancer
Similarity Score23%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSolid Tumor
Similarity Score15%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSolid Tumor

Worked with same sponsors:

Betta Pharmaceuticals Co., Ltd.
Similarity Score15%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Solid TumorCarcinoma, Non-Small-Cell Lung
Similarity Score15%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSolid Tumor
Similarity Score15%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSolid Tumor
Similarity Score15%

Jason Wu

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Related
31 trials

Shared therapeutic areas:

Solid TumorCarcinoma, Non-Small-Cell Lung
Similarity Score15%

jianxing he, MD

The First Affiliated Hospital of Guangzhou Medical University

Related
7 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Betta Pharmaceuticals Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Yanshan Huang, PhD

Zhejiang Doer Biologics Co., Ltd.

Related
3 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Zhejiang Doer Biologics Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Junfang Xu, MD

Huadong Medicine Co., Ltd.

Related
3 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Zhejiang Doer Biologics Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06132828Phase 1PrincipalInvestigator

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Solid Tumor
Recruiting
NCT05673590Phase 3PrincipalInvestigator

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Unknown
NCT04900363Phase 1/2PrincipalInvestigator

A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC

Non-small Cell Lung Cancer
Completed
NCT03838848Phase 2PrincipalInvestigator

KN046 in Patients With Advanced Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer
Terminated
NCT02448797Phase 3StudyChair

Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation

Non-small Cell Lung Cancer
Unknown

All 5 trials loaded